Viridian Therapeutics, Inc. announced on September 8, 2023, Kristian Humer, the Chief Financial Officer of the company resigned, effective September 12, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.18 USD | -0.16% | -3.79% | -44.08% |
Jun. 11 | Sector Update: Health Care Stocks Mixed Premarket Tuesday | MT |
Jun. 11 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.08% | 777M | |
+34.01% | 51.07B | |
+33.84% | 38.86B | |
-8.02% | 38.78B | |
-8.98% | 26.69B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- VRDN Stock
- News Viridian Therapeutics, Inc.
- Viridian Therapeutics, Inc. Announces Resignation of Kristian Humer as Chief Financial Officer